| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |